Show simple item record

contributor authorJan B. Pietzsch
contributor authorLauren M. Aquino
contributor authorPaul G. Yock
contributor authorM. Elisabeth Paté-Cornell
contributor authorJohn H. Linehan
date accessioned2017-05-09T00:25:16Z
date available2017-05-09T00:25:16Z
date copyrightDecember, 2007
date issued2007
identifier issn1932-6181
identifier otherJMDOA4-27987#283_1.pdf
identifier urihttp://yetl.yabesh.ir/yetl/handle/yetl/136570
description abstractMedical device regulation plays a significant role in the design, development, and commercialization of new medical technologies. A comprehensive understanding of the various regulatory requirements and their practical implementation is thus an essential cornerstone of successful medical device innovation. In this paper, we review the background, mission, and statutory requirements of medical device regulation in the United States. As opposed to pharmaceuticals, which have been regulated since the early 1900s, medical device regulation was not enacted before 1976, when Congress signed into law the Medical Device Amendments to the Federal Food, Drug and Cosmetic Act of 1938. The U.S. Food and Drug Administration (FDA) has implemented a risk-based classification system, which is essential in determining the regulatory pathway for a given device. Our review of the different regulatory pathways discusses the specific steps and requirements associated with each pathway, and their implications for development and testing of different types of devices. The differences in these pathways are significant, and thus require careful consideration and analysis already at early stages of development. The FDA’s Quality Systems Regulation, which outlines specific requirements for development, testing, production, and postmarket surveillance, is another important aspect of device regulation. We present its elements and relationship to design controls and other operating procedures implemented by device manufacturers, and discuss their relevance in ensuring the safety and effectiveness of marketed devices. A summary of recent additions to device regulation, implemented by the FDA to allow for adequate regulation of products that combine drugs and devices or biologics and devices (so-called combination products), completes our review. Because of the significance of device regulation for medical device innovation, we strongly support increased efforts to educate the various stakeholders involved in the medical device development process, both at the academic and professional level.
publisherThe American Society of Mechanical Engineers (ASME)
titleReview of U.S. Medical Device Regulation
typeJournal Paper
journal volume1
journal issue4
journal titleJournal of Medical Devices
identifier doi10.1115/1.2812429
journal fristpage283
journal lastpage292
identifier eissn1932-619X
keywordsSafety
keywordsMedical devices
keywordsFrequency-domain analysis
keywordsDesign
keywordsDrugs
keywordsRegulations AND Surveillance
treeJournal of Medical Devices:;2007:;volume( 001 ):;issue: 004
contenttypeFulltext


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record